• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Extending political will into action in African LMICs: abating global antimicrobial resistance.

作者信息

Aruhomukama Dickson

机构信息

Department of Immunology and Molecular Biology and Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala 7062, Uganda.

出版信息

Lancet Microbe. 2022 May;3(5):e327-e328. doi: 10.1016/S2666-5247(22)00063-5. Epub 2022 Mar 22.

DOI:10.1016/S2666-5247(22)00063-5
PMID:35544090
Abstract
摘要

相似文献

1
Extending political will into action in African LMICs: abating global antimicrobial resistance.将政治意愿转化为非洲低收入和中等收入国家的实际行动：减轻全球抗菌药物耐药性
Lancet Microbe. 2022 May;3(5):e327-e328. doi: 10.1016/S2666-5247(22)00063-5. Epub 2022 Mar 22.
2
Antimicrobial resistance in low- and middle-income countries: current status and future directions.中低收入国家的抗微生物药物耐药性：现状和未来方向。
Expert Rev Anti Infect Ther. 2022 Feb;20(2):147-160. doi: 10.1080/14787210.2021.1951705. Epub 2021 Jul 19.
3
Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.低收入和中等收入国家（以孟加拉国为例）新冠疫情后抗菌药物耐药性威胁
Front Public Health. 2021 Dec 17;9:770593. doi: 10.3389/fpubh.2021.770593. eCollection 2021.
4
Global surveillance of antimicrobial resistance and hypervirulence in Klebsiella pneumoniae from LMICs: An in-silico approach.全球范围内对来自中低收入国家的肺炎克雷伯菌的抗微生物药物耐药性和超级毒力的监测：一种计算机模拟方法。
Sci Total Environ. 2022 Jan 1;802:149859. doi: 10.1016/j.scitotenv.2021.149859. Epub 2021 Aug 25.
5
Creating political commitment for antimicrobial resistance in developing countries.在发展中国家为抗微生物药物耐药性问题争取政治支持。
Indian J Med Res. 2019 Feb;149(2):83-86. doi: 10.4103/ijmr.IJMR_1980_17.
6
Policy entrepreneurs are integral in efforts to curb antimicrobial resistance in low and middle income countries.政策企业家在中低收入国家遏制抗菌药物耐药性的努力中不可或缺。
Front Public Health. 2024 Mar 12;12:1292660. doi: 10.3389/fpubh.2024.1292660. eCollection 2024.
7
Benchmarking national action plans on antimicrobial resistance in eight selected LMICs: Focus on the veterinary sector strategies.在八个选定的中低收入国家对标评估抗菌药物耐药性国家行动计划：关注兽医部门战略。
J Glob Health. 2020 Dec;10(2):020414. doi: 10.7189/jogh.10.020414.
8
Differential Drivers of Antimicrobial Resistance across the World.全球抗菌药物耐药性的差异驱动因素。
Acc Chem Res. 2019 Apr 16;52(4):916-924. doi: 10.1021/acs.accounts.8b00643. Epub 2019 Mar 8.
9
Antimicrobial resistance: translating political commitment into national action.抗微生物药物耐药性：将政治承诺转化为国家行动。
Bull World Health Organ. 2017 Apr 1;95(4):242. doi: 10.2471/BLT.17.191890.
10
Developing bespoke antimicrobials to combat antimicrobial resistance in low- and middle-income countries: A critical appraisal of clinical utility in the elderly.开发定制抗菌药物以应对低收入和中等收入国家的抗菌药物耐药性：对老年人临床效用的批判性评估
Maturitas. 2023 Apr;170:74-75. doi: 10.1016/j.maturitas.2022.11.007. Epub 2022 Dec 2.

引用本文的文献

1
Policy entrepreneurs are integral in efforts to curb antimicrobial resistance in low and middle income countries.政策企业家在中低收入国家遏制抗菌药物耐药性的努力中不可或缺。
Front Public Health. 2024 Mar 12;12:1292660. doi: 10.3389/fpubh.2024.1292660. eCollection 2024.
2
Health systems appraisal of the response to antimicrobial resistance in low- and middle-income countries in relation to COVID-19: Application of the WHO building blocks.低收入和中等收入国家针对与2019冠状病毒病相关的抗菌药物耐药性应对措施的卫生系统评估：世界卫生组织基本要素的应用
Glob Policy. 2023 Nov;14(5):790-796. doi: 10.1111/1758-5899.13262. Epub 2023 Aug 22.
3
Investigating the evolution and predicting the future outlook of antimicrobial resistance in sub-saharan Africa using phenotypic data for Klebsiella pneumoniae: a 12-year analysis.
利用肺炎克雷伯菌表型数据研究撒哈拉以南非洲地区抗菌药物耐药性的演变并预测其未来趋势：一项为期 12 年的分析。
BMC Microbiol. 2023 Aug 8;23(1):214. doi: 10.1186/s12866-023-02966-y.